The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ANI Pharmaceuticals (ANIP) one of those stocks right now? A ...

Truist analyst Les Sulewski raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $65 from $62 and keeps a Hold rating on the shares ...

During the last three months, 6 analysts shared their evaluations of ANI Pharmaceuticals ANIP, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their ...

ANI Pharmaceuticals has a 12 month low of $52.50 and a 12 month high of $70.00. The stock has a market capitalization of $1.44 billion, a P/E ratio of -120.02 and a beta of 0.49.

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts to drive manufacturing back to the U.S. Drug imports evaded the ...

The Delhi HC refused to stay the takedown order against sections of the Wikipedia page on news agency ANI, during an appeal filed by the online encyclopaedia on April 8. However, the court agreed ...

Has ANI Pharmaceuticals (ANIP) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that ...

SOUTH SAN FRANCISCO, Calif., April 4, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals ...

ANI Pharmaceuticals projects 2025 revenue between $756 million and $776 million. The rare disease segment, including Cortrophin Gel, is a major growth driver. ILUVIEN and YUTIQ, acquired from Alimera, ...

More information is available at the Company's website at www.amphastar.com. The Amphastar Pharmaceuticals' logo and other trademarks or service marks of Amphastar Pharmaceuticals, Inc., including ...